Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
10.1186/s13287-017-0694-z Summary Keywords GLP-1, GLP-1RAs, T2DM, glucose, mechanism Citation He X, Zhao W, Li P, Zhang Y, Li G, Su H, Lu B and Pang Z (2025) Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus
CRC Press, pp
[2] SGLT2 inhibitors (such as dapagliflozin or empagliflozin) offer cardiovascular and renal benefits alongside glucose-lowering effects and typically produce modest weight loss through urinary glucose excretion
thyroid disorders), infection, surgery, or certain medication
400 mg Other Ingredients: Xylitol, citric acid, malic acid, stearic acid, silica, natural lemon flavor, and turmeric extract (for color)
Development and Expanding Indications of GLP-1 Receptor Agonists In 2005, the United States (US) Food and Drug Administration approved the first GLP-1 receptor agonist, exenatide, for the treatment of type 2 diabetes (T2D)
US$ 27.69
US$ 26.46
US$ 25.60
US$ 21.29
US$ 27.86
US$ 28.96
US$ 27.45
US$ 28.06
US$ 24.87
US$ 20.09
US$ 24.50
US$ 20.16
